The demographic and biomedical case for late-life interventions in aging

Michael J. Rae, Robert N. Butler, Judith Campisi, Aubrey D N J De Grey, Caleb E. Finch, Michael Gough, George M. Martin, Jan Vijg, Kevin M. Perrott, Barbara J. Logan

Research output: Contribution to journalArticle

57 Citations (Scopus)

Abstract

The social and medical costs of the biological aging process are high and will rise rapidly in coming decades, creating an enormous challenge to societies worldwide. In recent decades, researchers have expanded their understanding of the underlying deleterious structural and physiological changes (aging damage) that underlie the progressive functional impairments, declining health, and rising mortality of aging humans and other organisms and have been able to intervene in the process in model organisms, even late in life. To preempt a global aging crisis, we advocate an ambitious global initiative to translate these findings into interventions for aging humans, using three complementary approaches to retard, arrest, and even reverse aging damage, extending and even restoring the period of youthful health and functionality of older people.

Original languageEnglish (US)
Article number40cm21
JournalScience Translational Medicine
Volume2
Issue number40
DOIs
StatePublished - Jul 14 2010

Fingerprint

Demography
Biological Phenomena
Health
Research Personnel
Costs and Cost Analysis
Mortality
preempt

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Rae, M. J., Butler, R. N., Campisi, J., De Grey, A. D. N. J., Finch, C. E., Gough, M., ... Logan, B. J. (2010). The demographic and biomedical case for late-life interventions in aging. Science Translational Medicine, 2(40), [40cm21]. https://doi.org/10.1126/scitranslmed.3000822

The demographic and biomedical case for late-life interventions in aging. / Rae, Michael J.; Butler, Robert N.; Campisi, Judith; De Grey, Aubrey D N J; Finch, Caleb E.; Gough, Michael; Martin, George M.; Vijg, Jan; Perrott, Kevin M.; Logan, Barbara J.

In: Science Translational Medicine, Vol. 2, No. 40, 40cm21, 14.07.2010.

Research output: Contribution to journalArticle

Rae, MJ, Butler, RN, Campisi, J, De Grey, ADNJ, Finch, CE, Gough, M, Martin, GM, Vijg, J, Perrott, KM & Logan, BJ 2010, 'The demographic and biomedical case for late-life interventions in aging', Science Translational Medicine, vol. 2, no. 40, 40cm21. https://doi.org/10.1126/scitranslmed.3000822
Rae MJ, Butler RN, Campisi J, De Grey ADNJ, Finch CE, Gough M et al. The demographic and biomedical case for late-life interventions in aging. Science Translational Medicine. 2010 Jul 14;2(40). 40cm21. https://doi.org/10.1126/scitranslmed.3000822
Rae, Michael J. ; Butler, Robert N. ; Campisi, Judith ; De Grey, Aubrey D N J ; Finch, Caleb E. ; Gough, Michael ; Martin, George M. ; Vijg, Jan ; Perrott, Kevin M. ; Logan, Barbara J. / The demographic and biomedical case for late-life interventions in aging. In: Science Translational Medicine. 2010 ; Vol. 2, No. 40.
@article{b1b6f51ae204436e954410412954dc1d,
title = "The demographic and biomedical case for late-life interventions in aging",
abstract = "The social and medical costs of the biological aging process are high and will rise rapidly in coming decades, creating an enormous challenge to societies worldwide. In recent decades, researchers have expanded their understanding of the underlying deleterious structural and physiological changes (aging damage) that underlie the progressive functional impairments, declining health, and rising mortality of aging humans and other organisms and have been able to intervene in the process in model organisms, even late in life. To preempt a global aging crisis, we advocate an ambitious global initiative to translate these findings into interventions for aging humans, using three complementary approaches to retard, arrest, and even reverse aging damage, extending and even restoring the period of youthful health and functionality of older people.",
author = "Rae, {Michael J.} and Butler, {Robert N.} and Judith Campisi and {De Grey}, {Aubrey D N J} and Finch, {Caleb E.} and Michael Gough and Martin, {George M.} and Jan Vijg and Perrott, {Kevin M.} and Logan, {Barbara J.}",
year = "2010",
month = "7",
day = "14",
doi = "10.1126/scitranslmed.3000822",
language = "English (US)",
volume = "2",
journal = "Science Translational Medicine",
issn = "1946-6234",
publisher = "American Association for the Advancement of Science",
number = "40",

}

TY - JOUR

T1 - The demographic and biomedical case for late-life interventions in aging

AU - Rae, Michael J.

AU - Butler, Robert N.

AU - Campisi, Judith

AU - De Grey, Aubrey D N J

AU - Finch, Caleb E.

AU - Gough, Michael

AU - Martin, George M.

AU - Vijg, Jan

AU - Perrott, Kevin M.

AU - Logan, Barbara J.

PY - 2010/7/14

Y1 - 2010/7/14

N2 - The social and medical costs of the biological aging process are high and will rise rapidly in coming decades, creating an enormous challenge to societies worldwide. In recent decades, researchers have expanded their understanding of the underlying deleterious structural and physiological changes (aging damage) that underlie the progressive functional impairments, declining health, and rising mortality of aging humans and other organisms and have been able to intervene in the process in model organisms, even late in life. To preempt a global aging crisis, we advocate an ambitious global initiative to translate these findings into interventions for aging humans, using three complementary approaches to retard, arrest, and even reverse aging damage, extending and even restoring the period of youthful health and functionality of older people.

AB - The social and medical costs of the biological aging process are high and will rise rapidly in coming decades, creating an enormous challenge to societies worldwide. In recent decades, researchers have expanded their understanding of the underlying deleterious structural and physiological changes (aging damage) that underlie the progressive functional impairments, declining health, and rising mortality of aging humans and other organisms and have been able to intervene in the process in model organisms, even late in life. To preempt a global aging crisis, we advocate an ambitious global initiative to translate these findings into interventions for aging humans, using three complementary approaches to retard, arrest, and even reverse aging damage, extending and even restoring the period of youthful health and functionality of older people.

UR - http://www.scopus.com/inward/record.url?scp=77955650664&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955650664&partnerID=8YFLogxK

U2 - 10.1126/scitranslmed.3000822

DO - 10.1126/scitranslmed.3000822

M3 - Article

C2 - 20630854

AN - SCOPUS:77955650664

VL - 2

JO - Science Translational Medicine

JF - Science Translational Medicine

SN - 1946-6234

IS - 40

M1 - 40cm21

ER -